121 related articles for article (PubMed ID: 7507705)
1. Deletion mapping of the short arm of chromosome 3 in human malignant mesothelioma.
Lu YY; Jhanwar SC; Cheng JQ; Testa JR
Genes Chromosomes Cancer; 1994 Jan; 9(1):76-80. PubMed ID: 7507705
[TBL] [Abstract][Full Text] [Related]
2. Loss of heterozygosity on the short arm of chromosome 3 in mesothelioma cell lines and solid tumors.
Zeiger MA; Gnarra JR; Zbar B; Linehan WM; Pass HI
Genes Chromosomes Cancer; 1994 Sep; 11(1):15-20. PubMed ID: 7529042
[TBL] [Abstract][Full Text] [Related]
3. Recurring loss involving chromosomes 1, 3, and 22 in malignant mesothelioma: possible sites of tumor suppressor genes.
Flejter WL; Li FP; Antman KH; Testa JR
Genes Chromosomes Cancer; 1989 Nov; 1(2):148-54. PubMed ID: 2487155
[TBL] [Abstract][Full Text] [Related]
4. Submicroscopic deletions of 3p sequences in pleomorphic adenomas with t(3;8)(p21;q12).
Sahlin P; Mark J; Stenman G
Genes Chromosomes Cancer; 1994 Aug; 10(4):256-61. PubMed ID: 7522539
[TBL] [Abstract][Full Text] [Related]
5. Polymerase chain reaction-based restriction fragment length polymorphism analysis of the short arm of chromosome 3 in primary head and neck squamous carcinoma.
el-Naggar AK; Lee MS; Wang G; Luna MA; Goepfert H; Batsakis JG
Cancer; 1993 Aug; 72(3):881-6. PubMed ID: 8101470
[TBL] [Abstract][Full Text] [Related]
6. Loss of heterozygosity analysis of 13q and 14q in human malignant mesothelioma.
De Rienzo A; Jhanwar SC; Testa JR
Genes Chromosomes Cancer; 2000 Jul; 28(3):337-41. PubMed ID: 10862040
[TBL] [Abstract][Full Text] [Related]
7. Deletion mapping of the short arm of chromosome 3 in Merkel cell carcinoma.
Leonard JH; Williams G; Walters MK; Nancarrow DJ; Rabbitts PH
Genes Chromosomes Cancer; 1996 Feb; 15(2):102-7. PubMed ID: 8834173
[TBL] [Abstract][Full Text] [Related]
8. Investigation of tumor suppressor genes apart from VHL on 3p by deletion mapping in sporadic clear cell renal cell carcinoma (cRCC).
Singh RB; Amare Kadam PS
Urol Oncol; 2013 Oct; 31(7):1333-42. PubMed ID: 21962529
[TBL] [Abstract][Full Text] [Related]
9. PCR-based RFLP screening of the commonly deleted 3p loci in renal cortical neoplasms.
el-Naggar AK; Batsakis JG; Wang G; Lee MS
Diagn Mol Pathol; 1993 Dec; 2(4):269-76. PubMed ID: 7906993
[TBL] [Abstract][Full Text] [Related]
10. Mapping of chromosome 3p deletions in human epithelial ovarian tumors.
Lounis H; Mes-Masson AM; Dion F; Bradley WE; Seymour RJ; Provencher D; Tonin PN
Oncogene; 1998 Nov; 17(18):2359-65. PubMed ID: 9811467
[TBL] [Abstract][Full Text] [Related]
11. Multiple regions of allelic loss from chromosome arm 6q in malignant mesothelioma.
Bell DW; Jhanwar SC; Testa JR
Cancer Res; 1997 Sep; 57(18):4057-62. PubMed ID: 9307293
[TBL] [Abstract][Full Text] [Related]
12. Allelic 3p deletions in high-grade carcinomas after transformation in vitro of human uroepithelial cells.
Klingelhutz AJ; Wu SQ; Bookland EA; Reznikoff CA
Genes Chromosomes Cancer; 1991 Sep; 3(5):346-57. PubMed ID: 1686726
[TBL] [Abstract][Full Text] [Related]
13. Frequent involvement of chromosome 3p alterations in lung carcinogenesis: allelotypes of 215 established cell lines at six chromosome 3p loci.
Buchhagen DL
J Cell Biochem Suppl; 1996; 24():198-209. PubMed ID: 8806102
[TBL] [Abstract][Full Text] [Related]
14. Loss of heterozygosity analysis defines a critical region in chromosome 1p22 commonly deleted in human malignant mesothelioma.
Lee WC; Balsara B; Liu Z; Jhanwar SC; Testa JR
Cancer Res; 1996 Oct; 56(19):4297-301. PubMed ID: 8813110
[TBL] [Abstract][Full Text] [Related]
15. High resolution chromosome 3p allelotyping of human lung cancer and preneoplastic/preinvasive bronchial epithelium reveals multiple, discontinuous sites of 3p allele loss and three regions of frequent breakpoints.
Wistuba II; Behrens C; Virmani AK; Mele G; Milchgrub S; Girard L; Fondon JW; Garner HR; McKay B; Latif F; Lerman MI; Lam S; Gazdar AF; Minna JD
Cancer Res; 2000 Apr; 60(7):1949-60. PubMed ID: 10766185
[TBL] [Abstract][Full Text] [Related]
16. Analysis of 3p allelic loss in papillary and nonpapillary renal cell carcinomas. Correlation with tumor karyotypes.
Hughson MD; Meloni A; Dougherty S; Silva FG; Sandberg AA
Cancer Genet Cytogenet; 1996 Apr; 87(2):133-9. PubMed ID: 8625259
[TBL] [Abstract][Full Text] [Related]
17. Somatic genetic alterations in human malignant mesothelioma (review).
Lee WC; Testa JR
Int J Oncol; 1999 Jan; 14(1):181-8. PubMed ID: 9863027
[TBL] [Abstract][Full Text] [Related]
18. Loss of heterozygosity analysis defines a 3-cM region of 15q commonly deleted in human malignant mesothelioma.
De Rienzo A; Balsara BR; Apostolou S; Jhanwar SC; Testa JR
Oncogene; 2001 Sep; 20(43):6245-9. PubMed ID: 11593434
[TBL] [Abstract][Full Text] [Related]
19. Detailed genetic and physical mapping of tumor suppressor loci on chromosome 3p in ovarian cancer.
Fullwood P; Marchini S; Rader JS; Martinez A; Macartney D; Broggini M; Morelli C; Barbanti-Brodano G; Maher ER; Latif F
Cancer Res; 1999 Sep; 59(18):4662-7. PubMed ID: 10493522
[TBL] [Abstract][Full Text] [Related]
20. Homozygous deletions within 9p21-p22 identify a small critical region of chromosomal loss in human malignant mesotheliomas.
Cheng JQ; Jhanwar SC; Lu YY; Testa JR
Cancer Res; 1993 Oct; 53(20):4761-3. PubMed ID: 8402655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
